OBJECTIVE

Decision-making about antireflux procedures (ARPs) to treat gastroesophageal reflux disease in children with neurologic impairment and gastrostomy tubes is challenging and likely influenced by physicians’ experience and perspectives. This study will explore physician attitudes about ARPs and determine if there are relationships to clinical practice and personal characteristics.

METHODS

This is a national observational cross-sectional study that used an electronic questionnaire addressing reported practice, attitudes regarding the ARPs, and responses to clinical vignettes. Participants were physicians in Canadian tertiary-care pediatric settings. Descriptive statistics were used to analyze physician attitudes. Multivariable logistic regression modeling was used to determine associations between physician and practice characteristics and likelihood to consider ARP.

RESULTS

Eighty three respondents represented 12 institutions, with a majority from general or complex care pediatrics. There was a wide disparity between likelihood to consider ARP in each clinical scenario. Likelihood to consider ARP ranged from to 19% to 78% depending on the scenario. Two scenarios were equally split in whether the respondent would offer an ARP. None of the demographic characteristics were significantly associated with likelihood to consider ARP. Often, gastrojejunostomy tubes alone were considered (56% to 68%).

CONCLUSIONS

There is considerable variability in physician attitudes toward and recommendations regarding ARPs to treat gastroesophageal reflux disease. We did not find a significant association with clinical experience or location of practice. More research is needed to define indications and outcomes for ARPs. This is a scenario where shared decision-making, bringing together physician and family knowledge and expertise, is likely the best course of action.

Gastroesophageal reflux disease (GERD) is an important comorbidity for children with neurologic impairment (NI), affecting up to 75%.1,2  GERD refers to the passage of gastric contents into the esophagus leading to troublesome symptoms and/or complications.3  GERD can impair nutrition, contribute to lung disease through secondary aspiration, and cause significant pain.4,58  The diagnosis of GERD in children with NI is complicated by their frequent inability to self-report symptoms, lack of a gold standard diagnostic test, and variable definitions across the literature.3,9  In addition, GERD symptoms frequently overlap with those of other conditions in this population, such as intestinal dysmotility, feeding intolerance, and visceral hyperalgesia.10  For the purposes of this study, symptoms such as vomiting, aspiration, and pain will be described as “GERD symptoms,” acknowledging that there may be other conditions contributing to the clinical presentation. This is consistent with real-world practice wherein physicians are often managing this cluster of symptoms without a discrete and confirmed diagnosis.

In cases of refractory GERD, guidelines recommend consideration of antireflux procedures (ARPs) - such as fundoplication and postpyloric feeding through gastrojejunostomy tubes (GJTs).3,9  However, these guidelines are difficult to apply to children with NI and gastrostomy feeds considering their comorbidities, fragility, and frequent communication impairments. Further, evidence for ARPs is weak with no clinical trials comparing ARP to medical therapy or comparing GJT to fundoplication. Observational data are conflicting in terms of the impact of ARPs on lung disease2,1113  and which ARP is superior at improving symptoms and mitigating complications of GERD.14  Further, adverse events with ARPs are more common in children with NI, including major complications such as intussusception with GJTs and wrap migration or failure with fundoplication.15 

Given the lack of evidence regarding ARPs, decision-making is challenging. There are no targeted tools or algorithms to support clinical decision-making regarding the use of ARPs in children with NI and gastrostomy. In making decisions, physicians are influenced by their own attitudes about different treatment options, organizational culture and constraints, and demographic and clinical characteristics of the child and family.15,16  A deeper understanding of these perspectives is needed to design and implement much-needed prospective studies and clinical trials. This study will specifically explore physician attitudes and reported practice regarding the ARP treatment options (fundoplication and GJTs) for GERD in children with NI and gastrostomy tubes in association with salient physician characteristics such as professional location and years of practice.

We conducted a cross-sectional electronic survey study of physicians who practice at tertiary-care pediatric hospitals in Canada between November 2021 and February 2022. The design and administration of the survey followed guidelines developed by Burns et al.17  This study was approved by the Conjoint Health Research Ethics Board at our institution.

The survey was codeveloped by a pediatric surgeon, a pediatric gastroenterologist, a pediatric emergency medicine/palliative care physician, and complex care/hospitalist physicians based on clinical experience and review of existing literature. This multispecialty team determined the survey topics, question stems (including clinical scenarios), and the response options for each question. The survey contained 3 sections: (1) participant demographics; (2) general questions about ARPs (diagnostic tests, potential risks and harms, perceived barriers); and (3) case-based questions designed to imitate “real world” clinical practice (Fig 1). Following a clinical vignette, respondents were asked to report their likelihood to consider an ARP and what treatments or interventions they would attempt before an ARP (full questionnaire in Supplemental Fig 5). The vignettes corresponded broadly to the following clinical scenarios: (1) severe aspiration events (“Severe Asp”); (2) moderate aspiration events (“Mod Asp”); (3) failure to thrive because of vomiting or GERD (“FTT”); and (4) pain possibly secondary to GERD (“Pain”). A 4-point Likert scale was used with space for written comments after each question.

FIGURE 1

Clinical scenarios and likelihood to consider ARP.

FIGURE 1

Clinical scenarios and likelihood to consider ARP.

Close modal

This instrument was pilot tested in 5 cognitive interviews with relevant pediatric specialists and subspecialists for content validity, question clarity, item interpretation, and item redundancy. Revisions were made after each interview. After the fifth interview, no further modifications were required. This survey was also reviewed by an expert in survey design. A final survey was created consisting of 8 demographic questions, 7 general ARP questions, and 4 clinical scenarios with 6 questions each. The survey was translated into French by a member of our research team with both French and English language proficiency.

Qualtrics software was used to administer the survey, collect, and store data. Invitations to participate were distributed by e-mail to all members of the relevant divisions at the 14 pediatric hospitals across Canada. Pediatric surgeons were recruited by e-mail invitation through the Canadian Association of Pediatric Surgeons. Potential participants were contacted using Dillman’s tailored design method for mixed-mode surveys.18  The introductory e-mail contained a link where the recipient could indicate their eligibility and express interest. A survey link was sent directly to each individual respondent to allow for tracking of response rates. A total of 3 reminders were sent at 1-week intervals. An implied consent form was presented before the survey.

Respondents were physicians who practice at tertiary-care pediatric hospitals in Canada and represent 1 of the following subspecialty groups: hospital or general pediatricians, complex care pediatricians, pediatric gastroenterologists, and pediatric surgeons. These subspecialties were chosen as those most likely to be involved in decision-making regarding the management of GERD in this complex population of children. The study is limited to tertiary care hospitals as these sites typically have access to ARPs. Additional eligibility criteria included the respondent having treated a child with GERD, NI, and enteral feeding in the past year and having the ability to respond in either English or French.

Descriptive statistics were calculated, including means with SD and interquartile ranges for continuous variables, and count with proportions for categorical variables. The primary outcome variable of likelihood to consider an ARP was coded as 2 categories (consider and do not consider) and physician characteristics were coded as years in practice (<10, 11–20, ≥30), subspecialty (hospital pediatrics or complex care, gastroenterology, surgery) and location of practice (province).

Bivariable association between potential predictor variables and likelihood to consider an ARP in each clinical scenario were determined using χ-square tests. In bivariable analyses, a significant level of 0.3 was used for variable selections. Any variable with P value < .3 was planned to be included in the multivariable models (although no associations reached this threshold). Multivariable logistic regression modeling was, therefore, conducted including all variables because of their clinical importance to determine if there were any independent effects on the primary outcome of physician consideration of ARP. Multiple imputation technique was used in a sensitivity analysis to account for any missing or incomplete information obtained from the surveys.

A total of 119 physicians indicated eligibility via the invitation link. Of those, 83 provided at least partial responses giving a response rate of 70%. Full responses were available for 76. Table 1 presents respondent characteristics. The majority of respondents represented hospital pediatrics, complex care, and/or general pediatrics, whereas 15% (n = 15) of respondents identified as gastroenterologists and 5% (n = 4) as pediatric surgeons. There was representation in this sample from every province with a tertiary care pediatric hospital and a total of 12 institutions.

TABLE 1

Respondent Characteristics

N = 83n (%)
Specialty 
 Hospital medicine 27 (32.5) 
 Complex care 15 (18.1) 
 Gastroenterology 15 (18.1) 
 General pediatrics 11 (13.3) 
 Pediatric surgery 4 (4.8) 
 Other 4 (4.8) 
 No response 7 (8.4) 
Province 
 Alberta 20 (24.1) 
 Quebec 20 (24.1) 
 Ontario 18 (21.7) 
 BC 7 (8.4) 
 Manitoba 6 (7.2) 
 Nova Scotia 3 (3.6) 
 Newfoundland 1 (1.2) 
 Saskatchewan 1 (1.2) 
 No response 7 (8.4) 
Years in practice 
 0–10 34 (40.9) 
 10–20 23 (27.7) 
 20–30 12 (14.5) 
 >30 7 (8.4) 
 No response 7 (8.4) 
Frequency of interaction with children on tube feeding 
 Daily 35 (42) 
 Weekly 32 (39) 
 Monthly 8 (10) 
 Less than monthly 1 (1) 
 No response 7 (8) 
Number of ARPs on your patients in the past year 
 More than 10 14 (17) 
 6–10 13 (16) 
 1–5 45 (54) 
 0 4 (5) 
 No response 7 (8) 
Reported comfort level with ARPs 
 Very comfortable 32 (39) 
 Moderately comfortable 35 (42) 
 Slightly comfortable 9 (11) 
 Not at all comfortable 0 (0) 
 No response 7 (8) 
N = 83n (%)
Specialty 
 Hospital medicine 27 (32.5) 
 Complex care 15 (18.1) 
 Gastroenterology 15 (18.1) 
 General pediatrics 11 (13.3) 
 Pediatric surgery 4 (4.8) 
 Other 4 (4.8) 
 No response 7 (8.4) 
Province 
 Alberta 20 (24.1) 
 Quebec 20 (24.1) 
 Ontario 18 (21.7) 
 BC 7 (8.4) 
 Manitoba 6 (7.2) 
 Nova Scotia 3 (3.6) 
 Newfoundland 1 (1.2) 
 Saskatchewan 1 (1.2) 
 No response 7 (8.4) 
Years in practice 
 0–10 34 (40.9) 
 10–20 23 (27.7) 
 20–30 12 (14.5) 
 >30 7 (8.4) 
 No response 7 (8.4) 
Frequency of interaction with children on tube feeding 
 Daily 35 (42) 
 Weekly 32 (39) 
 Monthly 8 (10) 
 Less than monthly 1 (1) 
 No response 7 (8) 
Number of ARPs on your patients in the past year 
 More than 10 14 (17) 
 6–10 13 (16) 
 1–5 45 (54) 
 0 4 (5) 
 No response 7 (8) 
Reported comfort level with ARPs 
 Very comfortable 32 (39) 
 Moderately comfortable 35 (42) 
 Slightly comfortable 9 (11) 
 Not at all comfortable 0 (0) 
 No response 7 (8) 

A summary of the clinical scenarios and likelihood to consider ARP is shown in Fig 1. Two of the scenarios (#1 – Severe Asp and #4 - Pain) were equally split with approximately half of respondents indicating that they were very or somewhat likely to consider ARP (n = 45, 56% for scenario 1 and n = 44, 57% for scenario 4), whereas the other half were somewhat or very unlikely to consider. Respondents were less likely to consider ARPs for scenario 2 (Mod Asp), wherein only 19% (n = 15) of them would consider this intervention. Scenario 3 (FTT) was most favored for ARP with 78% (n = 60) of respondents indicating they were very or somewhat likely to consider. When asked which ARP they are likely to present as an option (fundoplication or GJT), most respondents would offer GJT only (22% to 49%), whereas very few would offer only fundoplication (4% to 8%) (Supplemental Table 3). On bivariable analysis, none of the potential predictor variables studied were significantly associated with the respondents’ likelihood to consider an ARP in any of the clinical scenarios (Supplemental Table 4). Multivariable logistic regression was performed including all variables (because of suspected clinical importance) with a cutoff of statistical significance at P < .05. This likewise did not reveal any independent predictors of physician likelihood to consider ARP in any clinical scenario. There were missing responses in 7 surveys (8%), but sensitivity analysis suggested this does not significantly impact our results (Supplemental Information).

There were no respondents who indicated they would proceed immediately to ARP in any scenario, instead suggesting a wide range of diagnostic investigations or treatments to be considered before (Table 2). The most common intervention was feeding changes (including changing rate or volumes or switching to continuous feeding) with 49% to 90% of respondents choosing this option. Prokinetics were also commonly trialed, particularly in scenarios 1, 3, and 4 (73%, 86%, and 78% respectively). Some respondents would trial baclofen (13% to 32%), NJ tube feeds (23% to 52%), formula changes (38% to 76%), or blenderized diets (24% to 54%). Depending on the scenario, up to half of respondents (19% to 54%) also indicated they would attempt to treat a comorbid condition, most commonly sialorrhea.

TABLE 2

Treatments and Interventions Before ARP

Treatment or Intervention#1 (Severe Asp), n (%)#2 (Mod Asp), n (%)#3 (FTT), n (%)#4 (Pain), n (%)
Adjust feeds 72 (90) 66 (85) 66 (86) 67 (87) 
Change formula 48 (60) 48 (62) 56 (73) 54 (70) 
Blenderized diet 29 (36) 36 (46) 39 (51) 42 (55) 
Prokinetic medication 60 (75) 53 (68) 61 (79) 60 (78) 
Baclofen 17 (21) 16 (21) 13 (17) 24 (31) 
Nasojejunal tube 28 (35) 21 (27) 38 (49) 24 (31) 
Treat comorbidity 43 (54) 33 (42) 15 (19) 17 (22) 
Othera 25 (31) 11 (14) 10 (13) 9 (12) 
Treatment or Intervention#1 (Severe Asp), n (%)#2 (Mod Asp), n (%)#3 (FTT), n (%)#4 (Pain), n (%)
Adjust feeds 72 (90) 66 (85) 66 (86) 67 (87) 
Change formula 48 (60) 48 (62) 56 (73) 54 (70) 
Blenderized diet 29 (36) 36 (46) 39 (51) 42 (55) 
Prokinetic medication 60 (75) 53 (68) 61 (79) 60 (78) 
Baclofen 17 (21) 16 (21) 13 (17) 24 (31) 
Nasojejunal tube 28 (35) 21 (27) 38 (49) 24 (31) 
Treat comorbidity 43 (54) 33 (42) 15 (19) 17 (22) 
Othera 25 (31) 11 (14) 10 (13) 9 (12) 

Scenario 1 (n = 80), scenario 2 (n = 78), scenario 3 (n = 77), scenario 4 (n = 77).

a

Including medications (new or increased doses), subspecialist consultation (respirology, gastroenterology), additional investigations (sialogram, upper gastrointestinal series, gastric emptying scan, videofluoroscopic feeding study, bedside feeding assessment, immunodeficiency workup, metabolic testing, pH probe, impedance study, endoscopy), chest physio or airway clearance or cough assist, constipation treatment.

In terms of diagnostic testing before ARP, over half of respondents would order an upper gastrointestinal series for either GJT (n = 53, 64%) or fundoplication (n = 57, 69%). About one third would complete a gastric emptying scan (n = 30, 35% for GJT; n = 37, 45% for fundoplication) and progressively smaller numbers would request impedance studies (n = 16, 19% for GJT; n = 35, 42% for fundoplication), fluoroscopic evaluation of feeding and swallowing or videofluoroscopic feeding study (n = 30, 36% for GJT; n = 21, 25% for fundoplication) or pH probes (n = 12, 14% for GJT; n = 24, 29% for fundoplication) (Supplemental Fig 4). Aside from feeding and swallowing studies, all other diagnostic tests were more commonly ordered before fundoplication compared with GJT.

Respondents were asked about the perceived risks associated with fundoplication. Most were concerned the procedure would be ineffective (n = 60, 72% moderately or very concerned) or cause worsening GERD symptoms (n = 67, 81% moderately or very concerned) (Fig 2). For GJT, the highest levels of concern were regarding the need for continuous feeding (n = 62, 75% moderately or very concerned), need for emergent GJT changes (n = 60, 72% moderately or very concerned), and major late complications such as intussusception (n = 52, 63% moderately or very concerned) (Fig 3).

FIGURE 2

Concern for risks and harms of fundoplication.

FIGURE 2

Concern for risks and harms of fundoplication.

Close modal
FIGURE 3

Concern for risks and harms of GJT.

FIGURE 3

Concern for risks and harms of GJT.

Close modal

The majority of respondents indicated that it was very easy or somewhat easy (n = 57, 77%) to access GJT although one-quarter had difficulty accessing this procedure. Only half reported that it was very or somewhat easy (n = 39, 51%) to access fundoplication at their institution. Most respondents (70%) were concerned about the ability of patients or families to access tertiary care sites for either routine or emergent GJT care.

This study provided a broad overview of the opinions and reported-practice of tertiary-care based physicians across Canada with respect to the use of ARPs among children with NI and gastrostomy tubes. A substantial majority of respondents were pediatricians practicing in hospital medicine or complex care, corresponding to the higher numbers of these specialists in Canada. Our results, thereby, predominantly reflect the perspectives of this group. We discovered considerable practice variability with no clear relationship to subspecialty, experience, or location of practice, although we may not have achieved sufficient power to detect these differences. Some responses reflected issues with access to ARPs because of a variety of geographic barriers (distribution of population) and resource limitations (surgeon or radiologist availability), which likely also impact physician practice. The scenario considered most amenable to ARP was scenario 3 (FTT), which is consistent with available guidelines recommending ARP for refractory GERD symptoms and failure of intragastric feeds.3,16  Even still, nearly one-quarter of respondents would not offer an ARP in this scenario, raising questions about guideline awareness and adherence. The scenario that had the lowest likelihood of ARP was scenario 2 (Mod Asp), which presented a child with chronic lung disease and infrequent episodes of aspiration pneumonia. Interestingly, scenarios 1 (Severe Asp) and 4 (Pain) were evenly split in in terms of likelihood to consider ARP. To some degree, this variability may reflect the lack of evidence available to guide clinical decision-making, which is an established contributor to practice variability.17  No randomized controlled trials have established the effectiveness of GJT or fundoplication compared with nonsurgical management in children with NI and gastrostomy feeds. Observational studies have mainly conducted head-to-head comparison of GJT and fundoplication,14,18  including a meta-analysis (2015) finding no difference in mortality or frequency of pneumonia.19  Interestingly, most physicians did not consider ARPs to be second-line treatment, instead suggesting many other interventions they would attempt before ARP. For instance, many would trial prokinetics before ARP even though existing guidelines do not recommend prokinetic agents for treatment of GERD (except in severe refractory cases).3,9 

Respondents rated high levels of comfort with ARPs even though their reported practice varied considerably. We hypothesized that practices were often concordant within an institution and/or subspecialty but varied between them. Internally consistent practices could result in higher levels of physician comfort even with a lack of evidence. However, this association was not confirmed in our results. Other research suggests a dissociation between physician-reported comfort and clinical decision-making.20,21  It would thereby be possible to have comfort even if decision-making was not optimal or evidence-based. We cannot exclude the possibility that some variation could be because of different interpretations of the clinical scenarios. However, our results are supported by prior studies that report similar degrees of practice variation in the treatment of GERD. A large cross-sectional study in the United States revealed that the odds of undergoing an ARP in the southwest were twice that of the northeast, even after adjusting for age, case-mix, and case-volume.22  Another study by Goldin et al reported changing rates of ARPs in relation to common procedures, such as appendectomies, at 36 children’s hospitals in the United States between 2001 and 2006. The overall decline in ARPs was unequally distributed with institutional rates that ranged from 40 fewer per year to 10 greater per year in comparison with 2001.11  A national survey of pediatric surgeons also found that about 80% of them required an upper gastrointestinal series before ARP and only 13% required a pH probe, similar to the proportions in our study.23 

Existing evidence cannot determine who would benefit from an ARP, particularly in children with NI and other complex needs. There is a need for future research including large prospective, comparative studies that can determine crucial outcomes, such as impact on respiratory morbidity and GERD symptoms. Another area that is under-explored is the impact of ARP on child and family quality of life. One small prospective study suggested improvement with fundoplication in the short term.24  Another interview study with parents whose child had undergone ARP better reflected the complexity of these scenarios, highlighting how feeding tolerance, caregiving requirements, continuous feeding, and changes in health care utilization could also mediate the impact of these procedures on quality of life.25  It is also concerning that physicians may be under-appreciating and, thereby, under-treating GERD symptoms, particularly in scenario 4 (Pain). Existing evidence suggests that pain and other distressing symptoms are often overlooked in children with NI and other complex conditions,2628  whereas physicians may be more comfortable making decisions in the face of “objective” evidence, such as episodes of aspiration pneumonia or growth failure (as in scenarios 1 and 3).

Even as we strive to build a stronger evidence base informing the use of ARPs, the clinical issues and dilemmas persist. The complexity of these children’s care and the nonspecific nature of these symptoms alongside social and logistical variables complicates the development of guidelines and standardization on the use of ARPs. Intentional shared decision-making (SDM) is a valuable approach that could acknowledge the limitations of current evidence and allow for patient and parent values, goals, and preferences to be emphasized and incorporated.29  One framework suggests that for medical decisions where there is more than 1 reasonable option without a clearly favorable benefit to burden ratio, an in-depth exploration of family preferences can ensure that child and parent values align with the chosen option.30  Children with medical complexity (including NI) are less likely to be engaged in SDM,31,32  potentially because of the difficulty predicting outcomes in the setting of multiple comorbidities. However, these parents appreciate the complexity of these decisions and highly value their own involvement.32  Uncertainties in the decision for ARP and the child’s course should be acknowledged, which can further facilitate parents’ participation and comfort.32 

Although 70% of individuals indicating eligibility were included, this study enrolled a relatively small sample skewed largely toward pediatric hospital medicine and complex care physicians, limiting generalizability to other subspecialties. These nuanced and complex clinical scenarios are difficult to describe in a brief vignette. The diagnosis of GERD may not have been obvious, but vignettes were intentionally designed to reflect “real world” scenarios where formal diagnostic testing is seldom used. The survey underwent a structured, iterative process of development, including cognitive interviewing but not formal clinical sensibility testing, which would have strengthened our findings. The style of the questions may have inhibited respondents from communicating more details about their perspectives, although there was space for written comments after each question. The distribution of responses, with some scenarios having more positive responses for ARP, suggests that the questions could discriminate different practice styles. However, it remains possible that some of the variation in responses is related to different interpretations of the clinical scenarios. Other treatment options for GERD were not addressed in this study (such as surgical jejunostomy tube) as they are infrequently used in Canada. No concerns about this omission were raised in the cognitive interviews.

With the lack of evidence regarding the impact of ARPs on clinical and patient-centered outcomes, considerable variability exists in physician perspectives and reported practice. Strengthening the evidence base with prospective studies should be prioritized. As with many complex medical decisions, SDM would acknowledge the limitations in our knowledge and best incorporate patient and family preferences, values, and goals when approaching decisions about ARP.

We thank Dr Brent Hagel, Dr Tamara Simon, Dr Marialena Mouzaki, and Dr Sarah Lai for their assistance in developing and testing the questionnaire; and the contributions of our survey respondents.

The first draft of this manuscript was written by Dr Dewan. This study was presented as a poster presentation at the American Academy of Cerebral Palsy and Developmental Medicine conference in 2023. There are no prior publications or other submissions with any overlapping information, including studies and patients.

FUNDING: This study is supported by the University of Calgary and the Alberta Children’s Hospital Research Institute. These organizations had no role in study design, study conduct, writing or publication.

CONFLICT OF INTEREST DISCLOSURES: None of the authors have any conflict of interest related to this study.

1
Lauriti
G
,
Lisi
G
,
Lelli Chiesa
P
,
Zani
A
,
Pierro
A
.
Gastroesophageal reflux in children with neurological impairment: a systematic review and meta-analysis
.
Pediatr Surg Int
.
2018
;
34
(
11
):
1139
1149
2
Maret-Ouda
J
,
Santoni
G
,
Artama
M
, et al
.
Aspiration pneumonia after antireflux surgery among neurologically impaired children with GERD
.
J Pediatr Surg
.
2020
;
55
(
11
):
2408
2412
3
Rosen
R
,
Vandenplas
Y
,
Singendonk
M
, et al
.
Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
.
J Pediatr Gastroenterol Nutr
.
2018
;
66
(
3
):
516
554
4
Asgarshirazi
M
,
Farokhzadeh-Soltani
M
,
Keihanidost
Z
,
Shariat
M
.
Evaluation of feeding disorders including gastro-esophageal reflux and oropharyngeal dysfunction in children with cerebral palsy
.
J Family Reprod Health
.
2017
;
11
(
4
):
197
201
5
Del Giudice
E
,
Staiano
A
,
Capano
G
, et al
.
Gastrointestinal manifestations in children with cerebral palsy
.
Brain Dev
.
1999
;
21
(
5
):
307
311
6
Seddon
PC
,
Khan
Y
.
Respiratory problems in children with neurological impairment
.
Arch Dis Child
.
2003
;
88
(
1
):
75
78
7
Morton
RE
,
Wheatley
R
,
Minford
J
.
Respiratory tract infections due to direct and reflux aspiration in children with severe neurodisability
.
Dev Med Child Neurol
.
1999
;
41
(
5
):
329
334
8
Sullivan
PB
.
Gastrointestinal disorders in children with neurodevelopmental disabilities
.
Dev Disabil Res Rev
.
2008
;
14
(
2
):
128
136
9
Romano
C
,
van Wynckel
M
,
Hulst
J
, et al
.
European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment
.
J Pediatr Gastroenterol Nutr
.
2017
;
65
(
2
):
242
264
10
Hauer
J
.
Feeding intolerance in children with severe impairment of the central nervous system: strategies for treatment and prevention
.
Children (Basel)
.
2017
;
5
(
1
):
1
11
Goldin
AB
,
Garrison
M
,
Christakis
D
.
Variations between hospitals in antireflux procedures in children
.
Arch Pediatr Adolesc Med
.
2009
;
163
(
7
):
658
663
12
Jancelewicz
T
,
Lopez
ME
,
Downard
CD
, et al
.
Surgical management of gastroesophageal reflux disease (GERD) in children: a systematic review
.
J Pediatr Surg
.
2017
;
52
(
8
):
1228
1238
13
Srivastava
R
,
Berry
JG
,
Hall
M
, et al
.
Reflux related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study
.
BMJ
.
2009
;
339
:
b4411
14
Stone
B
,
Hester
G
,
Jackson
D
, et al
.
Effectiveness of fundoplication or gastrojejunal feeding in children with neurologic impairment
.
Hosp Pediatr
.
2017
;
7
(
3
):
140
148
15
Mathei
J
,
Coosemans
W
,
Nafteux
P
, et al
.
Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients
.
Surg Endosc
.
2008
;
22
(
4
):
1054
1059
16
Broekaert
IJ
,
Falconer
J
,
Bronsky
J
, et al
.
The use of jejunal tube feeding in children: a position paper by the gastroenterology and nutrition committees of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition 2019
.
J Pediatr Gastroenterol Nutr
.
2019
;
69
(
2
):
239
258
17
Landrigan
CP
,
Conway
PH
,
Stucky
ER
,
Chiang
VW
,
Ottolini
MC
.
Variation in pediatric hospitalists’ use of proven and unproven therapies: a study from the Pediatric Research in Inpatient Settings (PRIS) network
.
J Hosp Med
.
2008
;
3
(
4
):
292
298
18
Srivastava
R
,
Downey
EC
,
O’Gorman
M
, et al
.
Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease
.
Pediatrics
.
2009
;
123
(
1
):
338
345
19
Livingston
MH
,
Shawyer
AC
,
Rosenbaum
PL
,
Jones
SA
,
Walton
JM
. Fundoplication and gastrostomy versus percutaneous gastrojejunostomy for gastroesophageal reflux in children with neurologic impairment: a systematic review and meta-analysis. In:
Journal of Pediatric Surgery
.
Vol. 50
.
W.B. Saunders
;
2015
:
707
714
20
Meyer
AND
,
Payne
VL
,
Meeks
DW
,
Rao
R
,
Singh
H
.
Physicians’ diagnostic accuracy, confidence, and resource requests: a vignette study
.
JAMA Intern Med
.
2013
;
173
(
21
):
1952
1958
21
Friedman
CP
,
Gatti
GG
,
Franz
TM
, et al
.
Do physicians know when their diagnoses are correct? Implications for decision support and error reduction
.
J Gen Intern Med
.
2005
;
20
(
4
):
334
339
22
Short
HL
,
Zhu
W
,
McCracken
C
,
Travers
C
,
Waller
LA
,
Raval
MV
.
Exploring regional variability in utilization of antireflux surgery in children
.
J Surg Res
.
2017
;
214
:
49
56
23
LaRiviere
CA
,
Parimi
C
,
Huaco
JC
,
Acierno
SA
,
Garrison
MM
,
Goldin
AB
.
Variations in preoperative decision making for antireflux procedures in pediatric gastroesophageal reflux disease: a survey of pediatric surgeons
.
J Pediatr Surg
.
2011
;
46
(
6
):
1093
1098
24
Srivastava
R
,
Downey
EC
,
Feola
P
, et al
.
Quality of life of children with neurological impairment who receive a fundoplication for gastroesophageal reflux disease
.
J Hosp Med
.
2007
;
2
(
3
):
165
173
25
Mahant
S
,
Pastor
AC
,
Deoliveira
L
,
Nicholas
DB
,
Langer
JC
.
Well-being of children with neurologic impairment after fundoplication and gastrojejunostomy tube feeding
.
Pediatrics
.
2011
;
128
(
2
):
e395
e403
26
Feinstein
JA
,
Feudtner
C
,
Valuck
RJ
, et al
.
Identifying important clinical symptoms in children with severe neurological impairment using parent-reported outcomes of symptoms
.
JAMA Pediatr
.
2020
;
174
(
11
):
1114
1117
27
Sultan
T
,
Wong
C
.
Presence and grade of undertreatment of pain in children with cerebral palsy
.
Scand J Pain
.
2023
;
23
(
3
):
546
552
28
Steele
R
,
Siden
H
,
Cadell
S
, et al
.
Charting the territory: symptoms and functional assessment in children with progressive, non-curable conditions
.
Arch Dis Child
.
2014
;
99
(
8
):
754
762
29
Kon
AA
,
Morrison
W
.
Shared decision-making in pediatric practice: a broad view
.
Pediatrics
.
2018
;
142
(
Suppl 3
):
S129
S132
30
Opel
DJA
.
A 4-step framework for shared decision-making in pediatrics
.
Pediatrics
.
2018
;
142
(
Suppl 3
):
S149
S156
31
Lin
JL
,
Cohen
E
,
Sanders
LM
.
Shared decision making among children with medical complexity: results from a population-based survey
.
J Pediatr
.
2018
;
192
:
216
222
32
Lin
JL
,
Clark
CL
,
Halpern-Felsher
B
, et al
.
Parent perspectives in shared decision-making for children with medical complexity
.
Acad Pediatr
.
2020
;
20
(
8
):
1101
1108

Supplementary data